US Patent Issued to SPG Therapeutics on June 3 for "Tripartite androgen receptor eliminators, methods and uses thereof" (California Inventor)

ALEXANDRIA, Va., June 4 -- United States Patent no. 12,319,681, issued on June 3, was assigned to SPG Therapeutics Inc. (Northridge, Calif.).

"Tripartite androgen receptor eliminators, methods and uses thereof" was invented by Zory Shaposhnik (Northridge, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present specification discloses tripartite androgen receptor eliminators (AREs), pharmaceutical compositions and medicaments comprising such AREs, methods and uses for such AREs and compositions and medicaments, and methods and uses for AREs and compositions and medicaments for treating an androgen receptor signaling-mediated condition, disease or disorder."

The patent was filed on Sept. 13, 2022, u...